Clinical trial
A Randomized Study Comparing Dabigatran Etexilate Versus Warfarin in Chinese Patients With Nonvalvular Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention With Stenting (DES)
NCT03536611 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Study Comparing Dabigatran Etexilate Versus Warfarin in Chinese Patients With Nonvalvular Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention With Stenting (DES)
- Lead sponsor
- Shenyang Northern Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 1, 2018
- Completion date
- June 30, 2020
- Enrollment
- 1,120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.